CLINICAL_TRIALS
trial_result
· 2013-08-30
Clinical Trial Update: Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN) [Phase 4]
Summary
Phase 4 study of Metanx for diabetic peripheral neuropathy completed; results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pamlab, Inc. | Conditions: Type 2 Diabetic Peripheral Neuropathy (DPN) | Phase 4 | Status: COMPLETED | Results posted: 2013-08-30